cbd business funding that understands the category
specialty funders offer working capital to federally legal cbd and hemp retailers across all 50 states. some specialty funders consider stores that banks decline by policy — including shops reformulating product lines ahead of the november 2026 federal hemp ban. typical decision in 24-72 hours; funded amounts $10K to $500K, subject to underwriting. we do not fund state-licensed cannabis dispensaries.
why cbd retail gets declined by banks
if you have applied for a business loan with the words cbd, hemp, or wellness dispensary anywhere in your file, you already know how the conversation goes. the numbers never get read. the application dies in a compliance queue, and the decline letter cites policy, not performance.
the mechanics behind that are worth understanding, because they explain both why the door is closed and where the open door actually is. banks maintain restricted-category lists — sets of industries their compliance departments will not lend into regardless of the borrower's financials. cbd retail can appear on those lists for two reasons. the first is regulatory ambiguity: the FDA has never approved cbd as a food additive or dietary supplement, so even fully legal hemp products occupy a gray zone that bank risk models price as category risk. the second is simpler and more frustrating: many underwriters do not distinguish hemp from marijuana at all. the word cannabis appears somewhere in the file, the bank's anti-money-laundering obligations around federally illegal marijuana come to mind, and the application is filed under a category the bank cannot touch.
the controlled-substance distinction is important, but complete product legality is more complicated. under the 2018 farm bill, qualifying hemp was removed from the Controlled Substances Act, but the farm bill preserved FDA authority and does not make every cbd product lawful for every use. foods, dietary supplements, drugs, cosmetics, labeling, therapeutic claims, and interstate sales can face different federal and state requirements. marijuana — cannabis above that threshold, the product sold in state-licensed dispensaries — remains a schedule I controlled substance federally, whatever state law says. qualifying hemp and marijuana therefore sit in different controlled-substance regimes, while each cbd product still needs its own FDA, labeling, intended-use, and state-law analysis.
some commercial-finance providers consider lawful hemp and cbd retailers, usually examining deposits, consistency, time in business, existing obligations, and product mix. each provider controls eligibility, and a category-aware review does not guarantee approval.
what actually gets funded
the instrument that works for cbd retail is revenue-based funding — most commonly a merchant cash advance, which is typically documented as a purchase of future receivables. a provider purchases a fixed share of your future receivables in exchange for a lump sum today, and collects it through automatic debits sized against your sales. approval runs on your last 3 months of business bank statements: deposit volume, deposit consistency, negative balance days, and any existing advance positions. there is no collateral appraisal, no business plan, and no requirement that a bank's compliance department bless your product category.
for a compliant cbd retailer, card sales and deposits may provide the operating history a revenue-based provider reviews. amounts, timing, and eligibility vary by provider and underwriting. monthly bank deposits, operating history, existing obligations, and product legality can all affect a decision.
if the mechanics are new to you — factor rates, holdback, reconciliation, renewals — our how an mca works guide walks through the whole structure in plain english before you talk to anyone.
a note on the words: cbd store loans and hemp business loans
most owners searching for a cbd store loan or hemp business loans are picturing a term loan: borrow a lump sum, pay it back monthly with interest over a few years. it is worth being clear that this product mostly does not exist for this category. the banks that offer term loans may decline cbd retail under lender-specific policies. sba program eligibility and an individual participating lender's overlay are separate questions, so a lawful business should check the current rules and lender policy rather than assume automatic ineligibility.
what the market actually offers cbd and hemp retailers is the revenue-based structure described above — and calling it a loan in conversation is fine, but knowing the difference protects you at the contract stage. the contract generally states a fixed purchased amount and an estimated term, but legal classification depends on substance and applicable law. compare total payback, effective annualized cost, reconciliation, recourse, and required disclosures. the structure can have advantages for this category — speed, no collateral, underwriting that ignores the category label — and real costs, which is why we put a calculator on this page instead of a slogan. grant programs and hemp industry associations occasionally surface small awards for hemp businesses; they are worth an application when open, but they are slow, competitive, and not a working-capital plan.
the november 2026 federal hemp ban changes the underwriting
no conversation about cbd business funding in 2026 is honest without this section. section 781 of H.R. 5371, signed november 12, 2025, rewrites the federal definition of hemp effective november 12, 2026. the new definition counts total THC — including THCA and delta-8 — against the 0.3 percent threshold, caps finished consumable products at 0.4 milligrams of total THC per container, and excludes synthetic and converted cannabinoids entirely. legal analysts estimate roughly 95 percent of the intoxicating hemp market becomes non-compliant on that date. products that meet the hemp definition may still face FDA, labeling, intended-use, interstate-commerce, and state-law requirements.
funders read the same statute you do, and it has changed how they underwrite the category. the question a cbd file gets asked in 2026 is no longer just what are the deposits — it is what is the revenue mix. an underwriter looking at your statements wants to know how much of your monthly volume comes from products that survive november 12, 2026, and how much comes from delta-8, THCA flower, and other intoxicating hemp that does not. a store doing 80 percent of its volume in compliant tinctures and topicals underwrites close to a normal retail file. a store doing 60 percent of its volume in THCA flower is being underwritten on a revenue line with a statutory end date, and funders price and size accordingly.
two practical consequences follow. first, timing: funders underwrite trailing statements, so a store with intoxicating-hemp revenue presents a stronger file before that revenue falls than after. second, story: a file packaged with a credible transition plan — what you are restocking, what the compliant mix looks like, when the pivot happens — reads as a pivot rather than a decline-worthy dip. we cover the transition-specific funding picture in depth on our hemp ban financing page, including how funders treat post-ban revenue projections.
what cbd businesses use the capital for
the use cases we see in this category right now cluster around the transition, because that is where the money pressure is:
- inventory transition — selling through non-compliant product before the deadline and restocking compliant lines behind it. wholesale terms are unstable as suppliers face the same transition. operating retailers can use the hemp and cbd inventory financing checklist to separate documented restock costs from speculative replacement revenue.
- compliance testing costs — third-party lab panels to verify total-THC content under the new definition. reformulated lines need full testing before they can ship, and lab queues are lengthening as the entire category retests at once.
- coa documentation — certificates of analysis for every SKU, updated labeling to match, and the recordkeeping that keeps a compliant store demonstrably compliant. this is unglamorous spending that funders actually like to see, because it is the difference between a store that survives an inspection and one that does not.
- pivot restocking — building out the categories that replace intoxicating hemp revenue: compliant cbd lines, topicals, wellness products, kratom and kava where state law allows, and accessories. replacement categories often carry different margins, so replacing the revenue takes more shelf investment than the raw dollar gap suggests.
- the ordinary stuff — payroll and rent through the revenue gap, marketing the new mix, and bridging seasonal slowdowns. transition or not, a retail store still has a first of the month.
what funders need to see
the initial file is short: your last 3 months of business bank statements, a one-page application, and your ID. that is genuinely the whole starting package. from there, underwriters in this category are reading for a few specific things, and knowing them ahead of time lets you present the strongest version of your file:
- deposit consistency — steady weekly deposits matter more than one strong month. cash sales only count if they reach the bank account.
- negative days — days your account went below zero. a few are survivable with context; a pattern narrows your funder options.
- existing positions — current advances reduce the available amount, and disclosing them upfront keeps the deal alive. funders find them anyway.
- revenue mix and the plan — in this category specifically, a short written note on what share of revenue is ban-exposed and what the transition plan is can move a file from auto-decline to approved. we help you write that note.
- compliance posture — current COAs on file and clean labeling do not show up in bank statements, but at the offer stage they support the story that this is a durable, legal retailer worth funding.
our team packages the file before any funder sees it, and we send it only to the funders currently approving hemp and cbd retail — a smaller set than it was in 2024, and knowing who is still active is a large part of what a broker is for. if your file is not placeable yet, we say so and tell you what would change that.
run the numbers yourself
the calculator below shows how an advance actually prices: enter an amount, a factor rate, and an estimated term to see total payback, cost of capital, and the payment. everything runs in your browser and nothing here is an offer — actual terms come from the funder underwriting your file, with any disclosures your state requires. the full version with more context lives at our mca calculator.